What reconstitution means
Lyophilized (freeze-dried) peptides arrive as a dry powder. Before use in research, they must be dissolved - "reconstituted" - in a sterile liquid to create a solution of known concentration. The most common diluent for research peptides is bacteriostatic water, though sterile water for injection is sometimes used for single-dose preparations.
The reason peptides are supplied in lyophilized form is stability. In dry form, at appropriate temperatures, most peptides remain stable for years. In solution, degradation begins. Reconstituting only the amount needed for immediate use is the standard approach.
The concentration calculation
The concentration of a reconstituted solution depends on two things: the total amount of peptide in the vial (in milligrams or micrograms) and the volume of liquid added (in millilitres).
Concentration (mg/mL) = Peptide amount (mg) ÷ Volume added (mL)
Example: A 10 mg vial with 2 mL of bacteriostatic water added yields a concentration of 5 mg/mL (or 5,000 mcg/mL).
Example: The same 10 mg vial with 5 mL added yields 2 mg/mL (2,000 mcg/mL).
The choice of volume affects how much liquid must be drawn for each use. A more concentrated solution means smaller volumes per dose, which can be advantageous when working with small research subjects or when minimizing injection volume matters.
Step-by-step process
1. Allow the vial to come to room temperature. Cold vials can cause condensation that dilutes the powder before the diluent is added.
2. Wipe the vial septum with an alcohol swab. This reduces the risk of introducing contaminants.
3. Draw the diluent into the syringe. Use a sterile, appropriately sized syringe and needle.
4. Inject the diluent slowly down the side of the vial. Do not inject directly onto the powder - inject down the glass wall and let the liquid run down to the powder. This minimizes foaming and mechanical degradation.
5. Do not shake. Agitation can denature the peptide (disrupt its structure). Gentle swirling or rolling is acceptable. Some powders dissolve within seconds; others may take a few minutes.
6. Inspect the solution. It should be clear to slightly opalescent, with no visible particles. Cloudiness or precipitate may indicate an issue with the peptide, the diluent, or the reconstitution process.
Storage after reconstitution
Reconstituted solutions should be stored refrigerated (2–8°C) and used within the timeframe established in the relevant research protocol. Bacteriostatic water extends usable life compared to plain sterile water due to its benzyl alcohol preservative, but the peptide itself continues to degrade in solution regardless.
Label each vial with the concentration, date of reconstitution, and peptide identity. Freeze-thaw cycles should be minimized - if long-term storage of reconstituted solution is needed, aliquoting into single-use volumes before freezing is the standard approach.
References: Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov Today. 2015. General guidance from standard laboratory reconstitution protocols.
What reconstitution means
Lyophilized (freeze-dried) peptides arrive as a dry powder. Before use in research, they must be dissolved - "reconstituted" - in a sterile liquid to create a solution of known concentration. The most common diluent for research peptides is bacteriostatic water, though sterile water for injection is sometimes used for single-dose preparations.
The reason peptides are supplied in lyophilized form is stability. In dry form, at appropriate temperatures, most peptides remain stable for years. In solution, degradation begins. Reconstituting only the amount needed for immediate use is the standard approach.
The concentration calculation
The concentration of a reconstituted solution depends on two things: the total amount of peptide in the vial (in milligrams or micrograms) and the volume of liquid added (in millilitres).
Concentration (mg/mL) = Peptide amount (mg) ÷ Volume added (mL)
Example: A 10 mg vial with 2 mL of bacteriostatic water added yields a concentration of 5 mg/mL (or 5,000 mcg/mL).
Example: The same 10 mg vial with 5 mL added yields 2 mg/mL (2,000 mcg/mL).
The choice of volume affects how much liquid must be drawn for each use. A more concentrated solution means smaller volumes per dose, which can be advantageous when working with small research subjects or when minimizing injection volume matters.
Step-by-step process
1. Allow the vial to come to room temperature. Cold vials can cause condensation that dilutes the powder before the diluent is added.
2. Wipe the vial septum with an alcohol swab. This reduces the risk of introducing contaminants.
3. Draw the diluent into the syringe. Use a sterile, appropriately sized syringe and needle.
4. Inject the diluent slowly down the side of the vial. Do not inject directly onto the powder - inject down the glass wall and let the liquid run down to the powder. This minimizes foaming and mechanical degradation.
5. Do not shake. Agitation can denature the peptide (disrupt its structure). Gentle swirling or rolling is acceptable. Some powders dissolve within seconds; others may take a few minutes.
6. Inspect the solution. It should be clear to slightly opalescent, with no visible particles. Cloudiness or precipitate may indicate an issue with the peptide, the diluent, or the reconstitution process.
Storage after reconstitution
Reconstituted solutions should be stored refrigerated (2–8°C) and used within the timeframe established in the relevant research protocol. Bacteriostatic water extends usable life compared to plain sterile water due to its benzyl alcohol preservative, but the peptide itself continues to degrade in solution regardless.
Label each vial with the concentration, date of reconstitution, and peptide identity. Freeze-thaw cycles should be minimized - if long-term storage of reconstituted solution is needed, aliquoting into single-use volumes before freezing is the standard approach.
References: Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov Today. 2015. General guidance from standard laboratory reconstitution protocols.
